Aquestive Therapeutics Correlations

AQST Stock

USD 3.25 0.04 1.25%

The current 90-days correlation between Aquestive Therapeutics and Ironwood Pharmaceuticals is 0.26 (i.e., Modest diversification). The correlation of Aquestive Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Aquestive Therapeutics Correlation With Market

Modest diversification

The correlation between Aquestive Therapeutics and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aquestive Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Aquestive Stock please use our How to Invest in Aquestive Therapeutics guide.

Moving together with Aquestive Stock

0.64	CDIOW	Cardio Diagnostics	Pair Corr
0.75	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.78	ELVN	Enliven Therapeutics	Pair Corr
0.63	GPCR	Structure Therapeutics	Pair Corr
0.84	ZURA	Zura Bio Limited	Pair Corr
0.81	IMMX	Immix Biopharma	Pair Corr
0.87	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.69	PMVP	Pmv Pharmaceuticals	Pair Corr
0.66	PYXS	Pyxis Oncology	Pair Corr
0.63	SCLX	Scilex Holding	Pair Corr
0.64	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.74	ATNF	180 Life Sciences	Pair Corr

Moving against Aquestive Stock

0.79	SNY	Sanofi ADR	Pair Corr
0.75	AZN	AstraZeneca PLC ADR	Pair Corr
0.71	GILD	Gilead Sciences Sell-off Trend	Pair Corr
0.59	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.58	LLY	Eli Lilly	Pair Corr
0.57	PLX	Protalix Biotherapeutics	Pair Corr
0.56	OCX	OncoCyte Corp	Pair Corr
0.55	GOSS	Gossamer Bio	Pair Corr
0.78	AMGN	Amgen Inc	Pair Corr
0.67	DRMAW	Dermata Therapeutics	Pair Corr
0.55	CMPX	Compass Therapeutics	Pair Corr
0.52	NVCT	Nuvectis Pharma	Pair Corr
0.51	RVP	Retractable Technologies Earnings Call This Week	Pair Corr

Related Correlations Analysis

	EVOK	ADMP	GHSI	ACRX	DVAX	AMPH	LNTH	ANIP	IRWD	ALKS
EVOK		0.0	0.0	0.0	-0.54	0.51	-0.76	-0.6	0.33	-0.2	EVOK
ADMP	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ADMP
GHSI	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	GHSI
ACRX	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	ACRX
DVAX	-0.54	0.0	0.0	0.0		-0.8	0.41	0.56	-0.73	0.7	DVAX
AMPH	0.51	0.0	0.0	0.0	-0.8		-0.26	-0.75	0.88	-0.8	AMPH
LNTH	-0.76	0.0	0.0	0.0	0.41	-0.26		0.43	-0.09	-0.06	LNTH
ANIP	-0.6	0.0	0.0	0.0	0.56	-0.75	0.43		-0.71	0.62	ANIP
IRWD	0.33	0.0	0.0	0.0	-0.73	0.88	-0.09	-0.71		-0.87	IRWD
ALKS	-0.2	0.0	0.0	0.0	0.7	-0.8	-0.06	0.62	-0.87		ALKS
	EVOK	ADMP	GHSI	ACRX	DVAX	AMPH	LNTH	ANIP	IRWD	ALKS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

IRWD	+ 0.88	AMPH
ALKS	+ 0.7	DVAX
ALKS	+ 0.62	ANIP
ANIP	+ 0.56	DVAX
AMPH	+ 0.51	EVOK
ANIP	+ 0.43	LNTH

High negative correlations

ALKS	- 0.87	IRWD
ALKS	- 0.8	AMPH
AMPH	- 0.8	DVAX
LNTH	- 0.76	EVOK
ANIP	- 0.75	AMPH
IRWD	- 0.73	DVAX

Risk-Adjusted Indicators

There is a big difference between Aquestive Stock performing well and Aquestive Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aquestive Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EVOK	3.49	(0.54)	0.00	(0.45)	0.00	0.00	6.88	(8.02)	47.09
ADMP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GHSI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ACRX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
DVAX	1.05	0.12	0.10	0.75	1.36	(1.11)	2.36	(1.97)	7.23
AMPH	1.59	(0.52)	0.00	(1.43)	0.00	0.00	3.23	(4.12)	14.01
LNTH	2.21	0.10	0.05	(0.24)	2.70	(2.33)	3.49	(4.29)	21.39
ANIP	1.66	0.30	0.15	0.24	1.79	(1.97)	3.04	(2.99)	18.94
IRWD	4.14	(0.95)	0.00	(0.56)	0.00	0.00	5.67	(10.26)	52.86
ALKS	1.32	0.21	0.17	0.46	1.24	(1.61)	3.78	(2.44)	10.24

Aquestive Therapeutics Corporate Management

Carl MD	Chief Officer	Profile
Alexander Schobel	Chief Officer	Profile
BSBA Esq	Sr Counsel	Profile
Kenneth MD	Chief Officer	Profile
Kenneth Marshall	Chief Officer	Profile
Ernest Toth	Chief Officer	Profile
Stephen Wargacki	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC